# A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer

> **NCT07707531** · EARLY_PHASE1 · RECRUITING · sponsor: **Huashan Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Gastric Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** [68Ga]/ [131I]-IR199

## Key facts

- **NCT ID:** NCT07707531
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07707531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07707531, "A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled IR199 in Patients With Gastric Cancer and Pancreatic Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07707531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*